{"DataElement":{"publicId":"2180688","version":"2","preferredName":"Chronic Graft Versus Host Disease Transplant Outcome Grade","preferredDefinition":"the overall resulting outcome of chronic (long term) graft versus host disease reported for a patient who received a transplant.","longName":"CHR_GVHD_TSPL_OUT_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195875","version":"1","preferredName":"Chronic Graft Versus Host Disease Transplant Outcome","preferredDefinition":"information related to the outcome of chronic GVHD following transplant.","longName":"CHR_GVHD_TSPL_OUT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206479","version":"1","preferredName":"Chronic Graft Versus Host Disease","preferredDefinition":"A disease or condition that persists or progresses over a long period of time.:Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","longName":"C14141:C0018133","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C0018133","definition":"Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F6D6-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207626","version":"1","preferredName":"Transplant Result","preferredDefinition":"Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C12981:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2A84-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF6D030-0809-6EAF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180594","version":"2","preferredName":"Chronic Graft Versus Host Disease Grade","preferredDefinition":"information relating to the grade of chronic graft-versus-host disease.","longName":"CGVHD_GD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34EA476A-FC6B-25C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"ONEDATA","dateModified":"2007-07-10","deletedIndicator":"No"},{"value":"limited","valueDescription":"Limited GVHD involvement","ValueMeaning":{"publicId":"2663283","version":"1","preferredName":"Limited GVHD involvement","longName":"2663283","preferredDefinition":"Localized skin involvement and/or liver dysfunction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34EA4C0A-C38A-2E0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34EA476A-FC75-25C7-E044-0003BA3F9857","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"CAMPBELB","dateModified":"2007-07-10","deletedIndicator":"No"},{"value":"Extensive","valueDescription":"Extensive GVHD involvement","ValueMeaning":{"publicId":"2663282","version":"1","preferredName":"Extensive GVHD involvement","longName":"2663282","preferredDefinition":"One or more of the following: generalized skin involvement; or, liver histology showing chronic aggressive hepatitis, bridging necrosis or cirrhosis; or, involvement of eye: Schirmers test with < 5 mm wetting; or involvement of minor salivary glands or oral mucosa demonstrated on labial biopsy; or involvement of any other target organ","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34EA488D-B62F-2F1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34EA476A-FC7F-25C7-E044-0003BA3F9857","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"CAMPBELB","dateModified":"2007-07-10","deletedIndicator":"No"},{"value":"not evaluated","valueDescription":"Not Evaluated","ValueMeaning":{"publicId":"2570488","version":"1","preferredName":"Not Evaluated","longName":"2570488","preferredDefinition":"The non-affirmative response to a question.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E065-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2022-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34EA476A-FC89-25C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"ONEDATA","dateModified":"2007-07-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008573","version":"1","preferredName":"Adverse Event Results","preferredDefinition":"the outcome or resolution of the patient's adverse events.","longName":"AE_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB869948-5E78-2537-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34EA476A-FC56-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2811905","version":"1","longName":"Primary Amyloidosis","context":"CTEP"},{"publicId":"2811906","version":"1","longName":"Waldenstrom Macrogl","context":"CTEP"},{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811944","version":"1","longName":"NonHodgkins Lymphoma","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Overall Grade of Chronic GVHD","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"34EA58BC-7750-2DE2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-10","modifiedBy":"CAMPBELB","dateModified":"2007-07-10","changeDescription":"Replace VD with new NHLBI value meanings.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}